CLAUDIA PINEDA-MUYIR: Open Payments
NPI 1114166980 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,670 in 181 payments from 22 companies in 2025. Trend: 2023 $3,775 · 2024 $4,015 · 2025 $4,670
Food & beverage: $4,670
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $671 |
| Forte Bio-Pharma LLC | 15 | $585 |
| PFIZER INC. | 24 | $579 |
| Axsome Therapeutics, Inc. | 19 | $445 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $353 |
| Novo Nordisk Inc | 7 | $349 |
| Galderma Laboratories, L.P. | 6 | $224 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $201 |
| ABBVIE INC. | 10 | $181 |
| Amgen Inc. | 9 | $155 |
Products named: NURTEC ODT, PROLATE, Auvelity, Kerendia, Wegovy, NEMLUVIO, AIRSUPRA, JARDIANCE.
Industry payments across NY — which companies pay providers there.
